Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Logan

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Obstetrics and Gynecology|October 11, 2018
Hereditary Cancer Risk Assessment and Genetic Testing in the Community-Practice SettingMark S DeFrancesco, Richard N Waldman, Melissa M Pearlstone, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 20, 2014
Alectinib salvages CNS relapses in ALK-positive lung cancer patients previously treated with crizotinib and ceritinibJustin F Gainor, Carol A Sherman, Kathryn Willoughby, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 5, 2016
Alectinib Dose Escalation Reinduces Central Nervous System Responses in Patients with Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer Relapsing on Standard Dose AlectinibJustin F Gainor, Andrew S Chi, Jennifer Logan, et al.
Cancer Genetics|May 7, 2019
Prevalence and characteristics of likely-somatic variants in cancer susceptibility genes among individuals who had hereditary pan-cancer panel testingThomas P Slavin, Bradford Coffee, Ryan Bernhisel, et al.
Urologic Oncology|December 1, 2020
Prognostic capabilities and clinical utility of cell cycle progression testing, prostate imaging reporting and data system, version 2, and clinicopathologic data in management of localized prostate cancerDavid S Morris, J Scott Woods, Byard Edwards, et al.
Respirology (Carlton, Vic.)|July 1, 2025
The Risk-Benefit Balance of Oral Corticosteroid Treatment for Asthma Attacks: A Discrete Choice Experiment of Patients and Healthcare Professionals in the UK and New ZealandImran Howell, Jonathan Noble, Aleksandra Howell, et al.
Clinical and Translational Science|June 18, 2015
Process Improvement for Interinstitutional Research ContractingMichael Varner, Jennifer Logan, Todd Bjorklund, et al.
The Journal of Urology|January 31, 2015
Clinical implications of a multiparametric magnetic resonance imaging based nomogram applied to prostate cancer active surveillanceM Minhaj Siddiqui, Hong Truong, Soroush Rais-Bahrami, et al.
European Radiology|March 16, 2018
Correction to: A predictive model for distinguishing radiation necrosis from tumour progression after gamma knife radiosurgery based on radiomic features from MR imagesZijian Zhang, Jinzhong Yang, Angela Ho, et al.
European Radiology|November 28, 2017
A predictive model for distinguishing radiation necrosis from tumour progression after gamma knife radiosurgery based on radiomic features from MR imagesZijian Zhang, Jinzhong Yang, Angela Ho, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Obstetrics and Gynecology|October 11, 2018
Hereditary Cancer Risk Assessment and Genetic Testing in the Community-Practice SettingMark S DeFrancesco, Richard N Waldman, Melissa M Pearlstone, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 20, 2014
Alectinib salvages CNS relapses in ALK-positive lung cancer patients previously treated with crizotinib and ceritinibJustin F Gainor, Carol A Sherman, Kathryn Willoughby, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 5, 2016
Alectinib Dose Escalation Reinduces Central Nervous System Responses in Patients with Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer Relapsing on Standard Dose AlectinibJustin F Gainor, Andrew S Chi, Jennifer Logan, et al.
Cancer Genetics|May 7, 2019
Prevalence and characteristics of likely-somatic variants in cancer susceptibility genes among individuals who had hereditary pan-cancer panel testingThomas P Slavin, Bradford Coffee, Ryan Bernhisel, et al.
Urologic Oncology|December 1, 2020
Prognostic capabilities and clinical utility of cell cycle progression testing, prostate imaging reporting and data system, version 2, and clinicopathologic data in management of localized prostate cancerDavid S Morris, J Scott Woods, Byard Edwards, et al.
Respirology (Carlton, Vic.)|July 1, 2025
The Risk-Benefit Balance of Oral Corticosteroid Treatment for Asthma Attacks: A Discrete Choice Experiment of Patients and Healthcare Professionals in the UK and New ZealandImran Howell, Jonathan Noble, Aleksandra Howell, et al.
Clinical and Translational Science|June 18, 2015
Process Improvement for Interinstitutional Research ContractingMichael Varner, Jennifer Logan, Todd Bjorklund, et al.
The Journal of Urology|January 31, 2015
Clinical implications of a multiparametric magnetic resonance imaging based nomogram applied to prostate cancer active surveillanceM Minhaj Siddiqui, Hong Truong, Soroush Rais-Bahrami, et al.
European Radiology|March 16, 2018
Correction to: A predictive model for distinguishing radiation necrosis from tumour progression after gamma knife radiosurgery based on radiomic features from MR imagesZijian Zhang, Jinzhong Yang, Angela Ho, et al.
European Radiology|November 28, 2017
A predictive model for distinguishing radiation necrosis from tumour progression after gamma knife radiosurgery based on radiomic features from MR imagesZijian Zhang, Jinzhong Yang, Angela Ho, et al.
Pageof 4